SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3she'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E06_B_IPBB600_0
(ODORANT-BINDING
PROTEIN)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 4 ILE A 150
MET A 232
VAL A 310
GLY A 151
 None
 1.30A 1e06B-3sheA:
undetectable		 1e06B-3sheA:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FMO_E_ADNE351_1
(CAMP-DEPENDENT
PROTEIN KINASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		9 / 12 LEU A  50
GLY A  51
VAL A  58
ALA A  71
VAL A  98
ASN A 171
LEU A 173
THR A 186
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
I85  A 350 (-4.4A)
None
I85  A 350 ( 4.0A)
I85  A 350 (-3.3A)
 0.66A 1fmoE-3sheA:
20.6		 1fmoE-3sheA:
29.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IEP_A_STIA201_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LYS A  73
VAL A  98
ILE A 116
ARG A 165
 I85  A 350 (-2.8A)
None
None
None
 1.15A 1iepA-3sheA:
18.4		 1iepA-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IEP_B_STIB202_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 7 LYS A  73
VAL A  98
ILE A 116
ARG A 165
LEU A 173
 I85  A 350 (-2.8A)
None
None
None
None
 1.11A 1iepB-3sheA:
18.3		 1iepB-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LEU A  50
LYS A  73
ILE A 116
ARG A 165
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
 1.05A 1opjB-3sheA:
18.2		 1opjB-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1S8F_A_BEZA1501_0
(RAS-RELATED PROTEIN
RAB-9A)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 5 ILE A 281
TRP A 270
LEU A 285
PRO A 241
 None
 1.22A 1s8fA-3sheA:
undetectable
1s8fB-3sheA:
undetectable		 1s8fA-3sheA:
22.01
1s8fB-3sheA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YA3_A_STRA1001_1
(MINERALOCORTICOID
RECEPTOR)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 LEU A 235
LEU A 280
ALA A 277
LEU A 285
THR A 317
 None
 1.42A 1ya3A-3sheA:
undetectable		 1ya3A-3sheA:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CBR_A_A80A201_1
(PROTEIN (CRABP-I))		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 LEU A 115
VAL A 103
VAL A  85
GLY A  56
LEU A 173
 None
 1.05A 2cbrA-3sheA:
undetectable		 2cbrA-3sheA:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIN_W_CHDW1060_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 ILE A 231
MET A 335
THR A 336
LEU A 339
 None
 0.95A 2einN-3sheA:
2.5
2einW-3sheA:
undetectable		 2einN-3sheA:
19.73
2einW-3sheA:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EUF_B_LQQB401_1
(CELL DIVISION
PROTEIN KINASE 6)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 12 VAL A  58
LYS A  73
VAL A  98
ASN A 171
LEU A 173
ASP A 187
 I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
I85  A 350 (-4.4A)
None
I85  A 350 (-3.3A)
 0.66A 2eufB-3sheA:
21.5		 2eufB-3sheA:
25.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_A_MIXA539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		8 / 12 LEU A  50
GLY A  51
VAL A  58
ALA A  71
ASP A 166
LYS A 168
ASN A 171
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
None
I85  A 350 (-4.4A)
I85  A 350 (-3.3A)
 0.59A 2fumA-3sheA:
22.2		 2fumA-3sheA:
27.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_B_MIXB1539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		8 / 12 LEU A  50
GLY A  51
VAL A  58
ALA A  71
MET A 118
LYS A 168
ASN A 171
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
I85  A 350 (-4.4A)
I85  A 350 (-3.3A)
 0.65A 2fumB-3sheA:
22.3		 2fumB-3sheA:
27.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_C_MIXC2539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 12 LEU A  50
GLY A  51
VAL A  58
ALA A  71
MET A 118
ASN A 171
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
I85  A 350 (-4.4A)
 0.40A 2fumC-3sheA:
20.9		 2fumC-3sheA:
27.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_D_MIXD3539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 LEU A  50
GLY A  51
GLY A  53
VAL A  58
ALA A  71
LYS A 168
ASN A 171
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
I85  A 350 (-4.4A)
 0.85A 2fumD-3sheA:
20.8		 2fumD-3sheA:
27.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_D_MIXD3539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 LEU A  50
GLY A  51
VAL A  58
ALA A  71
MET A 118
LYS A 168
ASN A 171
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
I85  A 350 (-4.4A)
 0.67A 2fumD-3sheA:
20.8		 2fumD-3sheA:
27.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_A_STIA600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 6 LEU A  50
LYS A  73
VAL A  98
ILE A 116
ARG A 165
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
None
 0.99A 2hyyA-3sheA:
18.4		 2hyyA-3sheA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LEU A  50
LYS A  73
VAL A  98
ILE A 116
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
 0.72A 2hyyB-3sheA:
18.5		 2hyyB-3sheA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_B_FOLB401_1
(DIHYDROFOLATE
REDUCTASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		3 / 3 GLU A 140
GLN A 279
ARG A 282
 None
 0.80A 2w3bB-3sheA:
undetectable		 2w3bB-3sheA:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X45_A_HSMA1162_1
(ALLERGEN ARG R 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 4 GLU A 334
ASP A 324
HIS A 327
GLU A 330
 None
 1.32A 2x45A-3sheA:
undetectable		 2x45A-3sheA:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 12 ILE A 130
LEU A 321
ILE A 146
PRO A 240
PHE A 138
VAL A 310
 None
 1.33A 2ygqA-3sheA:
undetectable		 2ygqA-3sheA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG1_W_CHDW1059_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 ILE A 231
MET A 335
THR A 336
LEU A 339
 None
 0.81A 3ag1N-3sheA:
2.2
3ag1W-3sheA:
undetectable		 3ag1N-3sheA:
19.73
3ag1W-3sheA:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3C7Q_A_XINA1172_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		8 / 12 LEU A  50
GLY A  51
GLU A  60
ALA A  71
LYS A  73
VAL A  98
GLY A 124
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
None
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 (-3.0A)
None
 0.84A 3c7qA-3sheA:
18.2		 3c7qA-3sheA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 10 LEU A  50
VAL A  58
LYS A  73
VAL A  98
ILE A 116
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
None
 0.66A 3cs9A-3sheA:
18.4		 3cs9A-3sheA:
23.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 9 LEU A  50
VAL A  58
LYS A  73
VAL A  98
ILE A 116
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
None
None
 0.72A 3cs9B-3sheA:
19.0		 3cs9B-3sheA:
23.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_C_NILC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 LEU A  50
VAL A  58
LYS A  73
VAL A  98
ILE A 116
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
None
 0.68A 3cs9C-3sheA:
18.9		 3cs9C-3sheA:
23.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_D_NILD600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LEU A  50
VAL A  58
LYS A  73
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
 0.76A 3cs9D-3sheA:
17.2		 3cs9D-3sheA:
23.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EYG_A_MI1A1_1
(TYROSINE-PROTEIN
KINASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		11 / 12 LEU A  50
GLY A  51
GLY A  53
GLY A  56
VAL A  58
ALA A  71
LYS A  73
MET A 118
ASN A 171
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-3.1A)
None
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
I85  A 350 ( 3.9A)
I85  A 350 (-4.4A)
None
I85  A 350 (-3.3A)
 0.85A 3eygA-3sheA:
20.5		 3eygA-3sheA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FUP_A_MI1A1_1
(TYROSINE-PROTEIN
KINASE JAK2)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		9 / 12 LEU A  50
GLY A  51
GLY A  53
GLY A  56
VAL A  58
ALA A  71
LYS A  73
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-3.1A)
None
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 (-3.3A)
 0.99A 3fupA-3sheA:
20.3		 3fupA-3sheA:
26.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FUP_A_MI1A1_1
(TYROSINE-PROTEIN
KINASE JAK2)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		9 / 12 LEU A  50
GLY A  51
GLY A  56
VAL A  58
ALA A  71
LYS A  73
MET A 118
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
None
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
I85  A 350 ( 3.9A)
None
I85  A 350 (-3.3A)
 0.83A 3fupA-3sheA:
20.3		 3fupA-3sheA:
26.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FUP_B_MI1B1_1
(TYROSINE-PROTEIN
KINASE JAK2)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		8 / 12 LEU A  50
GLY A  51
VAL A  58
ALA A  71
LYS A  73
VAL A  98
MET A 118
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 ( 3.9A)
None
 0.62A 3fupB-3sheA:
20.3		 3fupB-3sheA:
26.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 7 LEU A  50
LYS A  73
ILE A 116
ARG A 165
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
 0.91A 3ik3A-3sheA:
18.7		 3ik3A-3sheA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 7 LEU A  50
LYS A  73
ILE A 116
ARG A 165
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
 0.82A 3ik3B-3sheA:
18.3		 3ik3B-3sheA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LEU A  50
LYS A  73
VAL A  98
ILE A 116
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
 0.69A 3k5vA-3sheA:
18.5		 3k5vA-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LEU A  50
LYS A  73
VAL A  98
ILE A 116
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
 0.67A 3k5vB-3sheA:
18.3		 3k5vB-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LXK_A_MI1A1125_1
(TYROSINE-PROTEIN
KINASE JAK3)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		9 / 12 LEU A  50
GLY A  51
VAL A  58
ALA A  71
LYS A  73
VAL A  98
MET A 118
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 ( 3.9A)
None
I85  A 350 (-3.3A)
 0.90A 3lxkA-3sheA:
20.5		 3lxkA-3sheA:
23.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MS9_A_STIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LYS A  73
VAL A  98
ILE A 116
ARG A 165
 I85  A 350 (-2.8A)
None
None
None
 0.80A 3ms9A-3sheA:
18.5		 3ms9A-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_A_STIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LYS A  73
VAL A  98
ILE A 116
ARG A 165
 I85  A 350 (-2.8A)
None
None
None
 0.81A 3mssA-3sheA:
18.5		 3mssA-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_C_STIC1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LYS A  73
VAL A  98
ILE A 116
ARG A 165
 I85  A 350 (-2.8A)
None
None
None
 0.82A 3mssC-3sheA:
18.5		 3mssC-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 VAL A  58
LYS A  73
VAL A  98
ILE A 116
 I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
None
 0.56A 3mssD-3sheA:
18.5		 3mssD-3sheA:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NXU_B_RITB600_2
(CYTOCHROME P450 3A4)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 ILE A 130
LEU A 172
THR A 175
ARG A 148
GLU A 145
 None
 1.34A 3nxuB-3sheA:
undetectable		 3nxuB-3sheA:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 LEU A  50
LYS A  73
ILE A 116
ARG A 165
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-2.8A)
None
None
None
 0.82A 3oxzA-3sheA:
18.9		 3oxzA-3sheA:
25.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_A_STIA3_2
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 LYS A  73
VAL A  98
ILE A 116
ARG A 165
 I85  A 350 (-2.8A)
None
None
None
 1.07A 3pyyA-3sheA:
18.6		 3pyyA-3sheA:
24.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UE4_A_DB8A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 ALA A  71
LYS A  73
GLU A  84
VAL A  98
ILE A 116
MET A 121
LEU A 173
 I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
None
None
None
None
 0.63A 3ue4A-3sheA:
20.3		 3ue4A-3sheA:
24.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UE4_A_DB8A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 LEU A  50
ALA A  71
LYS A  73
GLU A  84
ILE A 116
MET A 121
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
None
None
None
 0.79A 3ue4A-3sheA:
20.3		 3ue4A-3sheA:
24.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UQB_A_FK5A114_1
(UBIQUITIN-LIKE
PROTEIN SMT3,
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 8 VAL A 230
ILE A 231
ILE A 146
PHE A 127
 None
 0.90A 3uqbA-3sheA:
undetectable		 3uqbA-3sheA:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WG7_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 ILE A 231
MET A 335
THR A 336
LEU A 339
 None
 1.05A 3wg7N-3sheA:
2.2
3wg7W-3sheA:
undetectable		 3wg7N-3sheA:
19.73
3wg7W-3sheA:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_A_0LIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		8 / 12 LEU A  50
ALA A  71
LYS A  73
GLU A  84
LEU A 157
HIS A 164
ARG A 165
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
None
None
None
None
 1.09A 3zosA-3sheA:
17.9		 3zosA-3sheA:
24.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AN2_A_EUIA1382_1
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 LYS A  73
ILE A 116
MET A 118
ASP A 166
ASN A 171
 I85  A 350 (-2.8A)
None
I85  A 350 ( 3.9A)
None
I85  A 350 (-4.4A)
 0.75A 4an2A-3sheA:
18.3		 4an2A-3sheA:
25.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ANS_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 9 LEU A  50
VAL A  58
ALA A  71
MET A 118
MET A 121
GLY A 124
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
I85  A 350 (-3.0A)
None
 1.01A 4ansA-3sheA:
19.6		 4ansA-3sheA:
23.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		8 / 12 LEU A  50
VAL A  58
ALA A  71
LYS A  73
GLU A  84
GLY A 124
LEU A 157
HIS A 164
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 (-3.0A)
None
None
 0.85A 4asdA-3sheA:
18.3		 4asdA-3sheA:
22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CKI_A_ADNA2022_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 11 LEU A  50
GLY A  51
GLY A  53
VAL A  58
ALA A  71
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
 0.88A 4ckiA-3sheA:
20.9		 4ckiA-3sheA:
25.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DUB_A_LDPA501_1
(CYTOCHROME P450 BM3
VARIANT 9D7)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 PHE A 188
GLY A  94
PRO A  95
LEU A 157
 None
 0.71A 4dubA-3sheA:
undetectable		 4dubA-3sheA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DUB_B_LDPB501_1
(CYTOCHROME P450 BM3
VARIANT 9D7)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 PHE A 188
GLY A  94
PRO A  95
LEU A 157
 None
 0.72A 4dubB-3sheA:
undetectable		 4dubB-3sheA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HJO_A_AQ4A1001_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 LEU A  50
VAL A  58
ALA A  71
LYS A  73
MET A 121
LEU A 173
THR A 186
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
None
I85  A 350 ( 4.0A)
 0.98A 4hjoA-3sheA:
13.7		 4hjoA-3sheA:
23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HJO_A_AQ4A1001_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 LEU A  50
VAL A  58
LYS A  73
MET A 121
LEU A 173
THR A 186
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
None
I85  A 350 ( 4.0A)
I85  A 350 (-3.3A)
 1.08A 4hjoA-3sheA:
13.7		 4hjoA-3sheA:
23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I41_A_MIXA500_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 VAL A  58
ALA A  71
ASP A 166
LYS A 168
ASN A 171
LEU A 173
ASP A 187
 I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
None
I85  A 350 (-4.4A)
None
I85  A 350 (-3.3A)
 0.62A 4i41A-3sheA:
22.0		 4i41A-3sheA:
28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IAA_A_RTZA401_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 11 VAL A  58
ALA A  71
LYS A  73
GLU A 170
LEU A 173
ASP A 187
 I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
None
I85  A 350 (-3.3A)
 0.79A 4iaaA-3sheA:
21.7		 4iaaA-3sheA:
27.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L9I_A_8PRA601_1
(RHODOPSIN KINASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 7 VAL A  58
ALA A  71
LEU A  75
MET A 118
MET A 121
 I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
I85  A 350 ( 3.9A)
None
 0.93A 4l9iA-3sheA:
6.9		 4l9iA-3sheA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L9I_A_8PRA601_1
(RHODOPSIN KINASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 7 VAL A  58
ALA A  71
MET A 118
MET A 121
LEU A 173
 I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
None
 0.65A 4l9iA-3sheA:
6.9		 4l9iA-3sheA:
23.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4O0W_A_ADNA501_1
(AURORA KINASE A)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 6 LEU A  50
GLY A  51
VAL A  58
ALA A  71
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
 0.50A 4o0wA-3sheA:
21.8		 4o0wA-3sheA:
30.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_A_ADNA401_1
(CYCLIN-DEPENDENT
KINASE 9)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 8 GLY A  53
VAL A  58
ALA A  71
ASN A 171
LEU A 173
ASP A 187
 I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-4.4A)
None
I85  A 350 (-3.3A)
 0.66A 4ogrA-3sheA:
21.0		 4ogrA-3sheA:
26.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_E_ADNE401_1
(CYCLIN-DEPENDENT
KINASE 9)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 7 GLY A  51
ALA A  71
ASN A 171
LEU A 173
ASP A 187
 I85  A 350 (-3.5A)
I85  A 350 (-3.3A)
I85  A 350 (-4.4A)
None
I85  A 350 (-3.3A)
 0.74A 4ogrE-3sheA:
20.2		 4ogrE-3sheA:
26.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_I_ADNI401_1
(CYCLIN-DEPENDENT
KINASE 9)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 9 GLY A  53
VAL A  58
ALA A  71
ASN A 171
LEU A 173
ASP A 187
 I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-4.4A)
None
I85  A 350 (-3.3A)
 0.67A 4ogrI-3sheA:
21.1		 4ogrI-3sheA:
26.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OTI_A_MI1A1001_1
(SERINE/THREONINE-PRO
TEIN KINASE N1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 LEU A  50
GLY A  51
GLY A  56
VAL A  58
ALA A  71
VAL A  98
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
None
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
None
 0.55A 4otiA-3sheA:
19.7		 4otiA-3sheA:
28.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PB1_A_RBVA501_1
(NUPC FAMILY PROTEIN)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 GLY A 151
ALA A 153
LEU A 183
ASN A 171
ILE A 231
 None
None
None
I85  A 350 (-4.4A)
None
 1.14A 4pb1A-3sheA:
undetectable		 4pb1A-3sheA:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PD5_A_GEOA501_1
(NUPC FAMILY PROTEIN)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 GLY A 151
ALA A 153
LEU A 183
ASN A 171
ILE A 231
 None
None
None
I85  A 350 (-4.4A)
None
 1.15A 4pd5A-3sheA:
undetectable		 4pd5A-3sheA:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QRC_A_0LIA802_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 4)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 ALA A  71
GLU A  84
CYH A 120
LEU A 157
ARG A 165
 I85  A 350 (-3.3A)
None
I85  A 350 ( 3.8A)
None
None
 0.95A 4qrcA-3sheA:
12.9		 4qrcA-3sheA:
25.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WBO_B_ANWB601_0
(RHODOPSIN KINASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 8 LEU A  50
ALA A  71
MET A 118
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
 0.57A 4wboB-3sheA:
18.2		 4wboB-3sheA:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WBO_C_ANWC601_0
(RHODOPSIN KINASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 6 LEU A  50
ALA A  71
MET A 118
MET A 121
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
None
 0.59A 4wboC-3sheA:
18.4		 4wboC-3sheA:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XEY_A_1N1A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 12 LEU A  50
VAL A  58
ALA A  71
LYS A  73
VAL A  98
ILE A 116
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
None
None
 0.79A 4xeyA-3sheA:
19.9		 4xeyA-3sheA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 VAL A  58
ALA A  71
LYS A  73
ASP A 187
PHE A 188
 I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
I85  A 350 (-3.3A)
None
 0.62A 4xv2A-3sheA:
19.9		 4xv2A-3sheA:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AAB_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 10 LEU A  50
VAL A  58
ALA A  71
LYS A  73
MET A 121
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
None
I85  A 350 (-3.3A)
 1.01A 5aabA-3sheA:
19.6		 5aabA-3sheA:
23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FXT_A_0LAA1376_1
(DNA POLYMERASE III
SUBUNIT BETA)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 7 LEU A 285
PRO A 241
ILE A 234
LEU A 235
 None
 0.97A 5fxtA-3sheA:
undetectable		 5fxtA-3sheA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 GLY A  53
VAL A  58
ALA A  71
LYS A  73
ILE A 116
 I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
 0.65A 5hieA-3sheA:
3.4		 5hieA-3sheA:
26.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 GLY A  53
VAL A  58
ALA A  71
LYS A  73
ILE A 116
 I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
 0.67A 5hieB-3sheA:
19.9		 5hieB-3sheA:
26.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_C_P06C801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 12 GLY A  51
GLY A  53
VAL A  58
ALA A  71
LYS A  73
ASP A 187
 I85  A 350 (-3.5A)
I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
I85  A 350 (-3.3A)
 0.78A 5hieC-3sheA:
19.9		 5hieC-3sheA:
26.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_D_P06D801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 GLY A  53
VAL A  58
ALA A  71
LYS A  73
ILE A 116
 I85  A 350 (-3.1A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
 0.67A 5hieD-3sheA:
19.9		 5hieD-3sheA:
26.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KC4_E_RBFE201_1
(RIBOFLAVIN
TRANSPORTER RIBU)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 GLY A 229
MET A 232
LEU A 236
ALA A 277
PHE A 265
 None
 1.37A 5kc4E-3sheA:
undetectable		 5kc4E-3sheA:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LVN_A_ADNA402_1
(3-PHOSPHOINOSITIDE-D
EPENDENT PROTEIN
KINASE 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 11 LEU A  50
GLY A  51
VAL A  58
ALA A  71
VAL A  98
GLU A 125
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
None
None
 0.62A 5lvnA-3sheA:
21.5		 5lvnA-3sheA:
29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LVN_A_ADNA402_1
(3-PHOSPHOINOSITIDE-D
EPENDENT PROTEIN
KINASE 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 11 LEU A  50
GLY A  51
VAL A  58
ALA A  71
VAL A  98
GLU A 170
LEU A 173
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
None
None
 0.64A 5lvnA-3sheA:
21.5		 5lvnA-3sheA:
29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_B_ADNB401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 GLY A  51
VAL A  58
ALA A  71
MET A 118
MET A 121
 I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
 0.60A 5lw1B-3sheA:
11.1		 5lw1B-3sheA:
12.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_E_ADNE401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 10 GLY A  51
VAL A  58
ALA A  71
MET A 118
MET A 121
 I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
 0.65A 5lw1E-3sheA:
18.0		 5lw1E-3sheA:
12.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_H_ADNH401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 GLY A  51
VAL A  58
ALA A  71
MET A 118
MET A 121
 I85  A 350 (-3.5A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 ( 3.9A)
None
 0.51A 5lw1H-3sheA:
18.3		 5lw1H-3sheA:
12.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 10 LEU A  50
VAL A  58
LYS A  73
GLU A  84
ILE A 116
GLY A 124
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-2.8A)
None
None
I85  A 350 (-3.0A)
 0.86A 5mo4A-3sheA:
16.0		 5mo4A-3sheA:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N3H_A_NCAA401_0
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		7 / 10 LEU A  50
VAL A  58
ALA A  71
VAL A  98
MET A 118
LEU A 173
THR A 186
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
None
I85  A 350 ( 3.9A)
None
I85  A 350 ( 4.0A)
 0.75A 5n3hA-3sheA:
20.4		 5n3hA-3sheA:
29.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OWR_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 8 ALA A  71
GLU A  84
LEU A 173
ASP A 187
 I85  A 350 (-3.3A)
None
None
I85  A 350 (-3.3A)
 0.69A 5owrA-3sheA:
21.2		 5owrA-3sheA:
31.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W5V_A_ANWA701_0
(SERINE/THREONINE-PRO
TEIN KINASE TBK1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 ALA A  71
VAL A  98
MET A 118
GLY A 123
THR A 186
 I85  A 350 (-3.3A)
None
I85  A 350 ( 3.9A)
I85  A 350 (-4.3A)
I85  A 350 ( 4.0A)
 0.81A 5w5vA-3sheA:
4.2		 5w5vA-3sheA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W5V_A_ANWA701_0
(SERINE/THREONINE-PRO
TEIN KINASE TBK1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 ALA A  71
VAL A  98
MET A 118
GLY A 124
THR A 186
 I85  A 350 (-3.3A)
None
I85  A 350 ( 3.9A)
I85  A 350 (-3.0A)
I85  A 350 ( 4.0A)
 0.67A 5w5vA-3sheA:
4.2		 5w5vA-3sheA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W5V_A_ANWA701_0
(SERINE/THREONINE-PRO
TEIN KINASE TBK1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 9 LEU A  50
ALA A  71
VAL A  98
GLY A 124
THR A 186
 I85  A 350 (-3.7A)
I85  A 350 (-3.3A)
None
I85  A 350 (-3.0A)
I85  A 350 ( 4.0A)
 0.84A 5w5vA-3sheA:
4.2		 5w5vA-3sheA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XPR_A_K86A1201_1
(ENDOTHELIN B
RECEPTOR,ENDOLYSIN,E
NDOTHELIN B RECEPTOR)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 VAL A 167
LEU A 157
HIS A 158
ILE A  97
ALA A 153
 None
 1.47A 5xprA-3sheA:
1.9		 5xprA-3sheA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y80_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		8 / 12 LEU A  50
VAL A  58
ALA A  71
LYS A  73
GLU A  84
GLY A 124
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 (-3.0A)
None
I85  A 350 (-3.3A)
 0.80A 5y80A-3sheA:
21.8		 5y80A-3sheA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z86_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 ILE A 231
MET A 335
THR A 336
LEU A 339
 None
 1.00A 5z86N-3sheA:
2.0
5z86W-3sheA:
undetectable		 5z86N-3sheA:
19.73
5z86W-3sheA:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCO_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 6 ILE A 231
MET A 335
THR A 336
LEU A 339
 None
 1.00A 5zcoN-3sheA:
undetectable
5zcoW-3sheA:
undetectable		 5zcoN-3sheA:
19.73
5zcoW-3sheA:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZV2_B_LEVB801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		6 / 12 LEU A  50
VAL A  58
ALA A  71
LYS A  73
GLU A  84
GLY A 124
 I85  A 350 (-3.7A)
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 (-3.0A)
 0.65A 5zv2B-3sheA:
18.9		 5zv2B-3sheA:
11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A93_B_8NUB3001_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 5 ASP A 149
ILE A 130
PHE A 138
ASN A 305
 None
 1.21A 6a93B-3sheA:
3.1		 6a93B-3sheA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6IE8_A_CHDA201_0
(REGULATORY PROTEIN)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		5 / 12 LEU A 172
LEU A 339
ARG A 165
ASP A 224
LEU A 228
 None
 1.22A 6ie8A-3sheA:
undetectable		 6ie8A-3sheA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NMP_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3
(Homo
sapiens) 		4 / 7 ILE A 231
MET A 335
THR A 336
LEU A 339
 None
 0.79A 6nmpA-3sheA:
undetectable
6nmpJ-3sheA:
undetectable		 6nmpA-3sheA:
19.73
6nmpJ-3sheA:
13.65